The story of RBS is one of arrogance, hubris, and powerful men believing they are above the rules. These are perils that plague us just as much today as they did in 2008.

As a sales rep for drug manufacturers Questcor, Lisa Pratta always suspected the company’s business practices weren’t just ...

Frederick Barthelme’s short stories have to be among the saddest in the English language. A prolific author with a wider ...

Using social media as a pharma brand can feel risky due to regulatory constraints - but it can make a big impact when used in ...

In this Pharmaceutical Executive exclusive, Bob Jansen, David Shulkin, Gen. Paul Funk (Ret.), and Maj. Gen. Dennis LeMaster ...

The voluble billionaire discusses his mission to transform health care, why Kamala lost, the problem with Bluesky, and much ...

Tariffs, executive orders, and FTC probes are just some of the problems piling up for the pharmaceutical industry. Trump's actions are pressuring a historically "safe" sector.

President Donald Trump took on Big Pharma Monday with an executive order ... “I think, by the way, pharmaceutical – I have great respect for these companies and for the people that run them.

If this was a newspaper and not a nice shiny website plugged into the wall with a few blue cables coming out the back, then there is only one headline we would use on this story: Come again?

If this was a newspaper and not a nice shiny website plugged into the wall with a few blue cables coming out the back, then ...

PatientView surveyed more than 2,500 patient groups worldwide for its annual “Corporate Reputation of Pharma” report. This year, it examined the reputations of 46 Big Pharma companies — including the ...

Here’s a fun fact: There are more men named Robert on ... in seeing him ascend the pharma pay ladder so quickly. The majority of the executives’ earnings came from stock options, which is how Ricks ...